| Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients CD Wurster, B Winter, K Wollinsky, AC Ludolph, Z Uzelac, S Witzel, ... Journal of neurology 266, 183-194, 2019 | 111 | 2019 |
| Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis S Witzel, A Maier, R Steinbach, J Grosskreutz, JC Koch, A Sarikidi, S Petri, ... JAMA neurology 79 (2), 121-130, 2022 | 97 | 2022 |
| Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen CD Wurster, P Steinacker, R Günther, JC Koch, P Lingor, Z Uzelac, ... Journal of neurology 267, 36-44, 2020 | 56 | 2020 |
| Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment CD Wurster, R Günther, P Steinacker, J Dreyhaupt, K Wollinsky, Z Uzelac, ... Therapeutic Advances in Neurological Disorders 12, 1756286419846058, 2019 | 48 | 2019 |
| Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis J Dorst, J Schuster, J Dreyhaupt, S Witzel, JH Weishaupt, J Kassubek, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (9), 1007-1009, 2020 | 41 | 2020 |
| Routine cerebrospinal fluid (CSF) parameters in patients with spinal muscular atrophy (SMA) treated with nusinersen CD Wurster, JC Koch, I Cordts, J Dreyhaupt, M Otto, Z Uzelac, S Witzel, ... Frontiers in neurology 10, 1179, 2019 | 23 | 2019 |
| Comparing cardiac magnetic resonance–guided versus angiography-guided treatment of patients with stable coronary artery disease: results from a prospective randomized … D Buckert, S Witzel, JM Steinacker, W Rottbauer, P Bernhardt JACC: Cardiovascular Imaging 11 (7), 987-996, 2018 | 23 | 2018 |
| Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials S Witzel, F Frauhammer, P Steinacker, D Devos, PF Pradat, V Meininger, ... Translational Neurodegeneration 10, 1-12, 2021 | 22 | 2021 |
| Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study P Steinacker, E Feneberg, S Halbgebauer, S Witzel, F Verde, P Oeckl, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22 (3-4), 276-286, 2021 | 17 | 2021 |
| ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale A Maier, M Boentert, P Reilich, S Witzel, S Petri, J Großkreutz, ... Neurological research and practice 4 (1), 60, 2022 | 14 | 2022 |
| Fat-rich versus carbohydrate-rich nutrition in ALS: a randomised controlled study J Dorst, J Doenz, K Kandler, J Dreyhaupt, H Tumani, S Witzel, J Schuster, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (3), 298-302, 2022 | 14 | 2022 |
| Quality of life in SMA patients under treatment with nusinersen L Mix, B Winter, CD Wurster, S Platen, S Witzel, Z Uzelac, H Graf, ... Frontiers in neurology 12, 626787, 2021 | 14 | 2021 |
| German Motor Neuron Disease Network (MND-NET). Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral … S Witzel, A Maier, R Steinbach JAMA NEUROLOGY 79 (7), 727-727, 2022 | 13 | 2022 |
| Biomarkers for amyotrophic lateral sclerosis S Witzel, K Mayer, P Oeckl Current Opinion in Neurology 35 (5), 699-704, 2022 | 12 | 2022 |
| Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis A Catanese, S Rajkumar, D Sommer, P Masrori, N Hersmus, ... Brain 146 (9), 3770-3782, 2023 | 11 | 2023 |
| Clinical and genetic features of amyotrophic lateral sclerosis patients with C9orf72 mutations M Wiesenfarth, K Günther, K Müller, S Witzel, U Weiland, K Mayer, ... Brain Communications 5 (2), fcad087, 2023 | 9 | 2023 |
| Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers J Dorst, P Weydt, D Brenner, S Witzel, K Kandler, A Huss, C Herrmann, ... EBioMedicine 90, 2023 | 8 | 2023 |
| Mutation‐specific metabolic profiles in presymptomatic amyotrophic lateral sclerosis K Xia, S Witzel, C Witzel, V Klose, D Fan, AC Ludolph, J Dorst European Journal of Neurology 30 (1), 87-95, 2023 | 7 | 2023 |
| Fast versus slow disease progression in amyotrophic lateral sclerosis–clinical and genetic factors at the edges of the survival spectrum S Witzel, M Wagner, C Zhao, K Kandler, E Graf, R Berutti, K Oexle, ... Neurobiology of aging 119, 117-126, 2022 | 6 | 2022 |
| Phenotyping of the thoracic-onset variant of amyotrophic lateral sclerosis K Kandler, S Witzel, K Eder, D Rothenbacher, G Nagel, RS Peter, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (5), 563-565, 2022 | 4 | 2022 |
